Authors:
WILDEVUUR CRH
JANSEN PGM
BEZEMER PD
KUIK DJ
EIJSMAN L
BRUINS P
DEJONG AP
VANHARDEVELT FWJ
BIERVLIET JD
HASENKAM JM
KURE HH
KNUDSEN L
BELLAICHE L
AHLBURG P
LOISANCE DY
BAUFRETON C
LEBESNERAIS P
BAJAN G
MATTA A
VANDYCK M
RENOTTE MT
PONLOTLOIS A
BAELE P
MCGOVERN EA
MCCARTHY J
MCCARTHY A
ODONNELL A
FOSSE E
MOEN O
DREGELID E
BROCKMEIER V
ANDERSON C
POMAR JL
RANUCCI M
CONTI D
CIRRI S
CONTI E
DITTA A
VONSEGESSER LK
TKEBUCHAVA T
WEISS BM
TURINA MI
SVENNEVIG JL
MOHR B
VIDEM V
KARLSEN H
PEDERSEN TH
THELIN S
HALDEN E
HAGMAN L
THORNO E
AHLVIN E
Citation: Crh. Wildevuur et al., CLINICAL-EVALUATION OF DURAFLO(R)-II HEPARIN TREATED EXTRACORPOREAL-CIRCULATION CIRCUITS (2ND VERSION) - THE EUROPEAN WORKING GROUP ON HEPARIN COATED EXTRACORPOREAL-CIRCULATION CIRCUITS, European journal of cardio-thoracic surgery, 11(4), 1997, pp. 616-623
Citation: S. Wybraniec et Ap. Dejong, MODIFIED SAMPLING AND ANALYSIS METHOD FOR LARGE VOLATILITY RANGE AIRBORNE POLYCYCLIC AROMATIC-HYDROCARBONS (PAH) USING GAS-CHROMATOGRAPHY MASS-SPECTROMETRY, Fresenius' journal of analytical chemistry, 356(6), 1996, pp. 396-402